Proton therapy for cancer treatment

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
Devanshi Dinesh Mayani

Abstract

Proton beam therapy is the latest advancement in the treatment of various types of cancer. It is a precise form of radiotherapy. It uses a beam of protons to target the cancer cells and destroys them. It scores high on precision and effectiveness when compared to other conventional cancer treatments like surgery, chemotherapy and xray radiotherapy. Proton beam therapy destroys the cancerous cells without harming the healthy cells. Thus it considerably reduces the side-effects that accompany conventional cancer treatments. Supporters say the technology allows physicians to treat a broad spectrum of cancers with few adverse effects, while more precisely targeting tumor cells with higher doses of radiation. Detractors say proton beam therapy is hugely expensive and has not been shown to be superior to conventional radiation treatment. With proton beam therapy, physicians use a cyclotron to accelerate protons and fire them directly into tumor cells with submillimeter precision. Because healthy tissue is largely spared, oncologists can, in theory, deliver much higher doses of radiation, while improving local control and reducing the risk for recurrence and morbidities.

References

Jul 8, 1999·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·J E Munzenrider, N J Liebsch
Sep 2, 1999·Journal of Neurosurgery·E B HugJ M Slater
Dec 10, 2002·Archives of Ophthalmology·Evangelos GragoudasKathleen M Egan
Feb 18, 2004·International Journal of Radiation Oncology, Biology, Physics·W H St ClairN J Tarbell
May 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Jerry D SlaterJames M Slater
Jul 22, 2004·The Oncologist·David G Kirsch, Nancy J Tarbell
Jul 2, 2005·International Journal of Radiation Oncology, Biology, Physics·Renaud de CrevoisierDeborah A Kuban
Aug 23, 2005·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·Thomas E Byrne
Sep 29, 2005·British Journal of Cancer·W P LevinT F DeLaney
Oct 6, 2005·Physics in Medicine and Biology·J LambertM Jackson
Aug 22, 2007·Technology in Cancer Research & Treatment·Thomas F DeLaney
Dec 8, 2007·The British Journal of Educational Psychology·J BrownleeD Berthelsen
Sep 17, 2009·Annals of Internal Medicine·Joel E Tepper, A William Blackstock
Sep 17, 2009·Annals of Internal Medicine·Teruhiko TerasawaThomas A Trikalinos
Oct 16, 2009·Radiation Protection Dosimetry·Oliver Jäkel
Nov 1, 1946·Radiology·R R WILSON

❮ Previous
Next ❯

Citations

Apr 10, 2020·Current Drug Metabolism·Vishal ChavdaJun-O Jin
Jul 10, 2020·CNS & Neurological Disorders Drug Targets·Gautam KumarNitesh Kumar
Aug 28, 2021·International Journal of Molecular Sciences·Melanie KrebsChristian Peifer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Strahlentherapie
J E MunzenriderG Moulton
Australasian Radiology
T S LimY Zissiadis
International Journal of Radiation Oncology, Biology, Physics
Bertil DamatoR Douglas Errington
© 2021 Meta ULC. All rights reserved